Transmembrane TNF‐α mediates “forward” and “reverse” signaling, inducing cell death or survival via the NF‐κB pathway in Raji Burkitt lymphoma cells
Hailong Zhang,D. Yan,Xu Shi,Hui-fang Liang,Yan Pang,Na-lin Qin,Hui Chen,Jing Wang,Bingjiao Yin,Xiao-dan Jiang,Wei Feng,Wenjie Zhang,Muxiang Zhou,Zhuoya Li
DOI: https://doi.org/10.1189/jlb.0208078
2008-09-01
Journal of Leukocyte Biology
Abstract:Interestingly, some lymphoma cells, expressing high levels of transmembrane (tm)TNF‐α, are resistant to secretory (s)TNF‐α‐induced necrosis but sensitive to tmTNF‐α‐mediated apoptosis. As tmTNF‐α mediates “forward” as well as “reverse” signaling, we hypothesize that a balanced signaling between forward and reverse directions may play a critical role in determining the fate of cells bearing tmTNF‐α. Using Raji cells as a model, we first added exogenous tmTNF‐α on fixed, transfected NIH3T3 cells onto Raji cells to examine tmTNF‐α forward signaling and its effects, showing that constitutive NF‐κB activity and cellular inhibitor‐of‐apoptosis protein 1 transcription were down‐regulated, paralleled with Raji cell death. As Raji cells express tmTNF‐α, an inhibition of their tmTNF‐α expression by antisense oligonucleotide caused down‐regulation of NF‐κB activity. Conversely, increasing tmTNF‐α expression by suppressing expression of TNF‐α‐converting enzyme that cleaves tmTNF‐α led to an enhanced activation of NF‐κB, indicating that tmTNF‐α, but not sTNF‐α, contributes to constitutive NF‐κB activation. We next transfected Raji cells with a mutant tmTNF‐α lacking the intracellular domain to competitively suppress reverse signaling via tmTNF‐α; as expected, constitutive NF‐κB activity was decreased. In contrast, treating Raji cells with sTNFR2 to stimulate reverse signaling via tmTNF‐α ehanced NF‐κB activation. We conclude that tmTNF‐α, when highly expressed on tumor cells and acting as a receptor, promotes NF‐κB activation through reverse signaling, which is helpful to maintain tumor cell survival. On the contrary, tmTNF‐α, when acting as a ligand, inhibits NF‐κB activity through forward signaling, which is inclined to induce tumor cell death.
Biology